Monte Rosa Therapeutics, Inc

Intern, Synthetic Chemistry (6 Months)

Job Locations CH-Basel
ID
2026-1186
Category
Chemistry
Position Type
Intern
Min
CHF 20.00/Hr.
Max
CHF 35.00/Hr.

Overview

Monte Rosa Therapeutics is seeking passionate Intern in Synthetic Chemistry for 6 months to help us to eliminate disease causing proteins through targeted protein degradation - a novel and exciting way of drugging un-druggable proteins. You will work with an industry leader who will direct and mentor you on your project, bridging the medicinal chemistry team and the chemistry CRO in the design of synthetic chemistry routes of biological relevant compounds. You will join a diverse, thoughtful, fun and collaborative environment that emphasizes teamwork and putting people first!

Responsibilities

  • Design syntheses of target compounds.
  • Improve existing synthetic routes.
  • Understand synthetic chemistry issues affecting the project.
  • Utilize literature searches to solve specific research problems.
  • Being able to share technical knowledge in a written and oral format.
  • Learn, acquire and propose state-of-the-art synthetic methodologies.
  • Utilize training and resources (external and internal) to stay current in synthetic organic chemistry.

Qualifications

  • Master’s degree with 2-4 years industrial experience or PhD in Synthetic Organic Chemistry with laboratory-based experience.
  • Ability to simultaneously balance multiple tasks.
  • Show initiative to expand scope and depth of theoretical competence.
  • Independently plan work to support team and project objectives.
  • Work together with other members of a project team to accomplish team objectives.
  • Clearly communicate ideas and research results in written and oral format
  • Analytical data interpretation (e.g. NMR, LCMS)
  • Knowledge of literature search databases and chemistry software (e.g. Chemdraw).
  • Proven publication records preferable
  • Experience with molecular glues degraders/PROTACs is a plus but not required.

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed